BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

853 related articles for article (PubMed ID: 26292171)

  • 1. Mitogen-activated protein kinases and Hedgehog-GLI signaling in cancer: A crosstalk providing therapeutic opportunities?
    Rovida E; Stecca B
    Semin Cancer Biol; 2015 Dec; 35():154-67. PubMed ID: 26292171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cooperative integration between HEDGEHOG-GLI signalling and other oncogenic pathways: implications for cancer therapy.
    Pandolfi S; Stecca B
    Expert Rev Mol Med; 2015 Feb; 17():e5. PubMed ID: 25660620
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the hedgehog signaling by the mitogen-activated protein kinase cascade in gastric cancer.
    Seto M; Ohta M; Asaoka Y; Ikenoue T; Tada M; Miyabayashi K; Mohri D; Tanaka Y; Ijichi H; Tateishi K; Kanai F; Kawabe T; Omata M
    Mol Carcinog; 2009 Aug; 48(8):703-12. PubMed ID: 19142899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonclassical hedgehog-GLI signaling and its clinical implications.
    Shevde LA; Samant RS
    Int J Cancer; 2014 Jul; 135(1):1-6. PubMed ID: 23929208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer.
    Wei L; Xu Z
    Int J Cancer; 2011 Jul; 129(2):275-84. PubMed ID: 20839260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C-delta and mitogen-activated protein/extracellular signal-regulated kinase-1 control GLI activation in hedgehog signaling.
    Riobo NA; Haines GM; Emerson CP
    Cancer Res; 2006 Jan; 66(2):839-45. PubMed ID: 16424016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth.
    Pandolfi S; Montagnani V; Lapucci A; Stecca B
    Cell Death Differ; 2015 Dec; 22(12):2006-19. PubMed ID: 26024388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arsenic trioxide inhibits human cancer cell growth and tumor development in mice by blocking Hedgehog/GLI pathway.
    Beauchamp EM; Ringer L; Bulut G; Sajwan KP; Hall MD; Lee YC; Peaceman D; Ozdemirli M; Rodriguez O; Macdonald TJ; Albanese C; Toretsky JA; Uren A
    J Clin Invest; 2011 Jan; 121(1):148-60. PubMed ID: 21183792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crosstalk between hedgehog and other signaling pathways as a basis for combination therapies in cancer.
    Brechbiel J; Miller-Moslin K; Adjei AA
    Cancer Treat Rev; 2014 Jul; 40(6):750-9. PubMed ID: 24613036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between Wnt/β-catenin and Hedgehog/Gli signaling pathways in colon cancer and implications for therapy.
    Song L; Li ZY; Liu WP; Zhao MR
    Cancer Biol Ther; 2015; 16(1):1-7. PubMed ID: 25692617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phorbol esters inhibit the Hedgehog signalling pathway downstream of Suppressor of Fused, but upstream of Gli.
    Lauth M; Bergström A; Toftgård R
    Oncogene; 2007 Aug; 26(35):5163-8. PubMed ID: 17310984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hedgehog/GLI signaling in tumor immunity - new therapeutic opportunities and clinical implications.
    Grund-Gröschke S; Stockmaier G; Aberger F
    Cell Commun Signal; 2019 Dec; 17(1):172. PubMed ID: 31878932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor signaling synergizes with Hedgehog/GLI in oncogenic transformation via activation of the MEK/ERK/JUN pathway.
    Schnidar H; Eberl M; Klingler S; Mangelberger D; Kasper M; Hauser-Kronberger C; Regl G; Kroismayr R; Moriggl R; Sibilia M; Aberger F
    Cancer Res; 2009 Feb; 69(4):1284-92. PubMed ID: 19190345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hedgehog/GLI and PI3K signaling in the initiation and maintenance of chronic lymphocytic leukemia.
    Kern D; Regl G; Hofbauer SW; Altenhofer P; Achatz G; Dlugosz A; Schnidar H; Greil R; Hartmann TN; Aberger F
    Oncogene; 2015 Oct; 34(42):5341-51. PubMed ID: 25639866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hedgehog signaling pathway as a therapeutic target in various types of cancer.
    Onishi H; Katano M
    Cancer Sci; 2011 Oct; 102(10):1756-60. PubMed ID: 21679342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism.
    Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
    Cancer Lett; 2019 Feb; 442():341-350. PubMed ID: 30447254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naturally occurring small-molecule inhibitors of hedgehog/GLI-mediated transcription.
    Hosoya T; Arai MA; Koyano T; Kowithayakorn T; Ishibashi M
    Chembiochem; 2008 May; 9(7):1082-92. PubMed ID: 18357592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic KRAS activates hedgehog signaling pathway in pancreatic cancer cells.
    Ji Z; Mei FC; Xie J; Cheng X
    J Biol Chem; 2007 May; 282(19):14048-55. PubMed ID: 17353198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New hedgehog/GLI-signaling inhibitors from Adenium obesum.
    Arai MA; Tateno C; Koyano T; Kowithayakorn T; Kawabe S; Ishibashi M
    Org Biomol Chem; 2011 Feb; 9(4):1133-9. PubMed ID: 21170436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting GLI Transcription Factors in Cancer.
    Didiasova M; Schaefer L; Wygrecka M
    Molecules; 2018 Apr; 23(5):. PubMed ID: 29695137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.